Hyperfine Inc. has announced the enrollment of the first patients in the PRISM PMR study, which is designed to evaluate the clinical utility of the Swoop® portable MRI system in the operating room setting. The study aims to collect data on the use of portable MRI before and after neurosurgical procedures, assess its ability to detect post-operative complications such as stroke and bleeding, and examine its integration into surgical workflows. The PRISM PMR study is being conducted over three months at the Atlas Surgery Center in Buffalo, New York, under the leadership of Dr. Elad Levy. Results from the study have not yet been presented.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251021594224) on October 21, 2025, and is solely responsible for the information contained therein.